Posted by Michael Wonder on 08 Feb 2022
Free EpiPen campaign returns in response to overwhelming demand
8 February 2022 - Allergy New Zealand and Pub Charity have relaunched the successful FundaPen campaign to deliver 3,355 free lifesaving EpiPen auto-injectors to patients who have a doctor-diagnosed allergy and are at risk of anaphylaxis.
Lifesaving EpiPens which last only 12 – 18 months, are not currently funded by PHARMAC and can cost between $120 and $350 each. In the last 17 years, Allergy New Zealand has made eight submissions to have EpiPen auto-injectors publicly funded through PHARMAC.
